https://www.selleckchem.com/products/OSI-906.html
Several targeted therapies, which, for example, target the TNF, IL-17, IL-23, phosphodiesterase 4 or Janus kinase pathways, have shown significant efficacy in the treatment of enthesitis, resulting in improvement of function and quality of life for patients with PsA. © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology.In this review, we propose a model of PsA as a complex genetically determined autoimmune-mediated disease having a heterogeneous variety of subphenotypes, with each
Me gusta
Comentario
Compartir
